Organon
NJ · 8 filings, 2025
What the money shows
Organon reported $1.1M in federal lobbying for 2025 across 8 filings. The filings name 2 lobbying firms, led by Jeffrey J. Kimbell & Associates and Organon. The matched PAC file shows $10,000 to 0 lawmakers. The filing text lists 3 issue areas.
Sources: Senate LDA · FEC
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. via Wikipedia ↗
1Lobbies on
Its filings list: Medicare/Medicaid · Health Issues · Budget/Appropriations
2Through these firms · 2
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews